RSATS Mission 



May 19, 2021 | Specialized Programming and Treatment Issues for Veterans in Jails and Prisons


View and Register for Upcoming Webinars



HHS Releases New Buprenorphine Practice Guidelines, Expanding Access to Treatment for Opioid Use Disorder

Signed by HHS Secretary Xavier Becerra, the Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder exempt many medical personnel from federal certification requirements related to training, counseling and other ancillary services that are part of the process for obtaining a waiver to treat up to 30 patients with buprenorphine. The exemption applies only to the prescription of Schedule III, IV, and V drugs, including buprenorphine. It does not apply to Schedule II medications such as methadone. Practitioners are required to obtain a waiver from SAMHSA before treating patients with buprenorphine for OUD.



Medication-Assisted Treatment




Residential Substance Abuse Treatment for Juveniles
Treating Clients with Methamphetamine and Stimulant Use Disorder




New RSAT Training Film!

Jail MAT Begins with Immediate Clinical Intake!


View more RSAT-TTA Training Videos 


Search for programs around the country and in U.S. territories and click a site to view program information and link to each state's compendium.


Participate in our forum!

Inmates are charged more than $10 for a 15-minute call. We know that inmates who are able to stay in touch with their families are less likely to return to jail, yet the high price of these calls make that too expensive. Families who need the money are going into debt to pay for calls that on the outside costs far less. Jails get a “commission” from the telecommunication provider that has the contract for the system, so it has little incentive to negotiate lower prices. Are there any alternatives we can inform RSAT participants about?